Dr. Agarwal's Health Care Ltd. (IN:AGARWALEYE)
:AGARWALEYE
AGARWALEYE Stock Chart & Stats
₹500.00
--
Market closed
₹500.00
--
Day’s Range― - ―
52-Week Range₹327.40 - ₹567.80
Previous CloseN/A
VolumeN/A
Average Volume (3M)13.83K
Market Cap
₹134.74B
Enterprise Value₹142.39B
Total Cash (Recent Filing)₹3.97B
Total Debt (Recent Filing)₹9.83B
Price to Earnings (P/E)118.8
Beta0.58
Next Earnings
Jun 03, 2026EPS Estimate
1.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.10
Shares Outstanding316,807,500
10 Day Avg. Volume7,500
30 Day Avg. Volume13,832
Financial Highlights & Ratios
PEG Ratio43.43
Price to Book (P/B)7.19
Price to Sales (P/S)7.85
P/FCF Ratio589.13
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)5.6
Revenue Forecast (FY)₹24.77B
Bulls Say, Bears Say
Bulls Say
Revenue And Margin ImprovementSustained revenue growth with rising EBIT/EBITDA margins signals durable demand and better operational efficiency across clinics. Over 2–6 months this supports reinvestment in capacity, enhances cash flow conversion and underpins long-term profitability as volumes scale.
Consistent Operating Cash GenerationReliable operating cash flow and expanding free cash flow provide structural support for operations, capex and debt servicing. Strong cash conversion reduces refinancing risk, funds network expansion internally and enables steady funding of working capital needs over multiple quarters.
Scalable Network-based Eye Care ModelA multi-site ophthalmology network with surgical, outpatient and optical services creates diversified, recurring revenue streams. The hub-and-spoke model allows operating leverage as centers scale, supporting margin sustainability and competitive positioning in specialty eye care over the medium term.
Bears Say
Moderately High LeverageA moderately high debt-to-equity ratio raises structural financing risk: higher interest expense can pressure net margins and reduce flexibility for opportunistic investments. Over 2–6 months this increases sensitivity to cash flow swings and constrains balance sheet optionality.
Net Profit Margin VolatilityVolatile net margins suggest inconsistent control of non-operating costs or episodic expenses, which undermines earnings predictability. This instability can complicate multi-quarter planning, impair free cash flow visibility and limit confidence in sustaining shareholder returns.
Limited Public Guidance And Call DisclosuresAbsence of guidance and earnings-call detail reduces forward visibility into volume trends, pricing or capex plans. For investors and analysts this hampers reliable forecasting and assessment of management’s strategy, increasing uncertainty around medium-term performance execution.
Dr. Agarwal's Health Care Ltd. News
AGARWALEYE FAQ
What was Dr. Agarwal's Health Care Ltd.’s price range in the past 12 months?
Dr. Agarwal's Health Care Ltd. lowest stock price was ₹327.40 and its highest was ₹567.80 in the past 12 months.
What is Dr. Agarwal's Health Care Ltd.’s market cap?
Dr. Agarwal's Health Care Ltd.’s market cap is ₹134.74B.
When is Dr. Agarwal's Health Care Ltd.’s upcoming earnings report date?
Dr. Agarwal's Health Care Ltd.’s upcoming earnings report date is Jun 03, 2026 which is in 54 days.
How were Dr. Agarwal's Health Care Ltd.’s earnings last quarter?
Dr. Agarwal's Health Care Ltd. released its earnings results on Feb 13, 2026. The company reported ₹1.1 earnings per share for the quarter, beating the consensus estimate of ₹1 by ₹0.1.
Is Dr. Agarwal's Health Care Ltd. overvalued?
According to Wall Street analysts Dr. Agarwal's Health Care Ltd.’s price is currently Overvalued.
Does Dr. Agarwal's Health Care Ltd. pay dividends?
Dr. Agarwal's Health Care Ltd. does not currently pay dividends.
What is Dr. Agarwal's Health Care Ltd.’s EPS estimate?
Dr. Agarwal's Health Care Ltd.’s EPS estimate is 1.07.
How many shares outstanding does Dr. Agarwal's Health Care Ltd. have?
Dr. Agarwal's Health Care Ltd. has 316,807,500 shares outstanding.
What happened to Dr. Agarwal's Health Care Ltd.’s price movement after its last earnings report?
Dr. Agarwal's Health Care Ltd. reported an EPS of ₹1.1 in its last earnings report, beating expectations of ₹1. Following the earnings report the stock price went down -0.84%.
Which hedge fund is a major shareholder of Dr. Agarwal's Health Care Ltd.?
Currently, no hedge funds are holding shares in IN:AGARWALEYE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Dr. Agarwal's Health Care Ltd.
Dr. Agarwal's Health Care Limited operates eye hospitals in India and internationally. It offers cataract surgeries, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery, and glued intraocular lens treatments; and refractive surgeries, including surgical procedures to correct the refractive error of the eye to get rid of or reduce dependence on glasses and contact lens. The company also provides surgical retinal treatments, corneal transplantation and pinhole pupilloplasty, oculoplasty, and surgeries for the treatment of glaucoma and pterygium; doctor consultation services; and diagnostic services for eye disorders along with non-surgical treatments, including retinal laser therapy and dry eye treatment services. It also sells glasses, lenses, contact lenses, and frames; and eye care-related pharmaceutical products. The company was incorporated in 2010 and is based in Chennai, India.
Technical Analysis
HealthCare Global Enterprises Ltd.
―
Jupiter Life Line Hospitals Ltd.
―
Marksans Pharma Limited
―
Metropolis Healthcare Ltd.
―
Rainbow Childrens Medicare Limited
―